BYSI: BeyondSpring Inc. Stock

by  •  • Comments Off on BYSI: BeyondSpring Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 50.40
Enterprise Value ($M) 66.09
Book Value ($M) -14.29
Book Value / Share -0.35
Price / Book -3.53
NCAV ($M) -20.02
NCAV / Share -0.50
Price / NCAV -2.52

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) n/a
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 2.60
Current Ratio 2.60

Balance Sheet (mrq) ($M)
Current Assets 28.58
Assets 34.31
Liabilities 48.60
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -8.75
Net Income -11.12

Cash Flow Statement (mra) ($M)
Cash From Operations -16.44
Cash from Investing -12.01
Cash from Financing 26.79

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Ever Regal Group Ltd 15.01 -40.76
11-14 13G/A Decheng Capital Management III (Cayman), LLC 12.30 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 4,325 12,986 33.31
2025-04-16 7,746 14,270 54.28
2025-04-15 3,749 7,826 47.90
2025-04-14 3,538 7,372 47.99

(click for more detail)

Similar Companies
BON – Bon Natural Life Limited BTAI – BioXcel Therapeutics, Inc.
BULL – Webull Corporation CALC – CalciMedica, Inc.
CAPR – Capricor Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io